Diabetes
🇺🇸 FDA Page 3FDA news and analysis for pharmaceutical BD, investment, and market access · 6 articles on this page
Unlock global diabetes market insights. Get critical pharma intelligence on R&D, regulatory approvals, and investment opportunities for diabetes treatments.
Showing 25–30 of 30 articles
FDA Approves Sanofi's Tzield for Children Age 1+ to Delay Type 1 Diabetes Onset
Biosimilar Competition Impact: US Biologics Market Analysis 2026
Pulnovo Medical Secures $100 Million Investment from Medtronic for Pulmonary Hypertension Therapies
Lilly's Foundayo Shows 57% Mortality Reduction in Landmark ACHIEVE-4 Diabetes Trial
FDA Approves Biosimilar Insulin Lispro: What You Need to Know
AI in FDA Drug Approvals: What You Need to Know